Cali Biosciences Begins Phase III Study of Long-Acting Ropivacaine for Pain Reduction After Surgery

Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali" or "Cali Biosciences"), a biopharmaceutical company focused on the research and development o...

April 19, 2023 | Wednesday | News
Nona Biosciences & Washington University Partner to Combat RNA Viruses

"This collaboration represents an exciting opportunity for Nona Biosciences to leverage its fully human antibody H2L2 transgenic mice, together with the te...

April 19, 2023 | Wednesday | News
Xyall and Indica Labs collaborate to transform precision oncology workflows

Bridging the gap between histopathology and molecular pathology Xyall and Indica Labs have entered into a global strategic partnership designed to bridge ...

April 18, 2023 | Tuesday | News
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol

As disclosed in September 2022, Avenue received meeting minutes from the FDA regarding a Type A meeting conducted on August 9, 2022, for IV Tramadol. At th...

April 18, 2023 | Tuesday | News
Experience Asia's Leading Biotech Event: BIO Asia-Taiwan 2023

Asia’s largest bioindustry-focused gathering, BIO Asia–Taiwan 2023, will be held July 26th to 30th, 2023, in Taipei, Taiwan. Co-organized by BI...

April 18, 2023 | Tuesday | News
Agena Bioscience and nRichDX Partner for Liquid Biopsy Analyte Extraction and Detection Solutions

Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researcher...

April 17, 2023 | Monday | News
Atmo Biosciences strengthens U.S. focus with new board appointment and establishment of San Diego office

The increased presence in the U.S. comes as Atmo Biosciences prepares to begin a multi-site pivotal study to support a U.S. Food and Drug Administration (F...

April 17, 2023 | Monday | News
Imprivata Launches Healthcare Digital Identity Maturity Model and Assessment

Imprivata, the digital identity company for life-and mission-critical industries,  announced the launch of the Imprivata Digital Identity Maturity Mod...

April 17, 2023 | Monday | News
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions   Prometheus Biosciences&rs...

April 17, 2023 | Monday | News
Merck invests in largest specialty gases facility in Hometown, PA.

Agreement with the Commonwealth of Pennsylvania supports expansion of manufacturing capacities for the semiconductor industry The roughly € 300 mil...

April 14, 2023 | Friday | News
Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the init...

April 14, 2023 | Friday | News
Aspect Biosystems, Novo Nordisk partner to bioprint tissue therapies for diabetes, obesity.

Partnership will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation ...

April 14, 2023 | Friday | News
U.S. Food and Drug Administration Issues Complete Response Letter for Mirikizumab

"We remain confident in mirikizumab's pivotal Phase 3 clinical data and its potential to help people with ulcerative colitis," said Patrik Jonsson, Lilly e...

April 14, 2023 | Friday | Regulatory
ZyVersa Publishes Review Article on Targeting Microglial Inflammation in Alzheimer's Disease

During aging, the central nervous system (“CNS”) becomes more inflammatory, leading to activation of microglia (“CNS immune cells&rdquo...

April 13, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close